Key Highlights
•
A new study explores how the drug finerenone interacts with heart failure events and the development of new-onset diabetes in patients with a mildly reduced or preserved ejection fraction, providing insights into managing these overlapping conditions. This research is significant because it could help physicians better treat patients who face both heart failure and a high risk of diabetes, potentially improving their overall outcomes.
Source →
•
Researchers have engineered CAR T cells to produce a special sugar transporter (GLUT3) on demand, which boosts their energy and ability to fight glioblastoma brain tumors in lab models. This advance is crucial because it suggests a new way to make cell-based cancer therapies more effective against aggressive and hard-to-treat brain cancers.
Source →
•
A large review found that non-drug interventions, like counseling and skills training, can effectively reduce anxiety and depression in both cancer patients and their family caregivers, especially when delivered together. This is important because it offers practical, evidence-based ways to support the mental health of families facing a cancer diagnosis, which can lead to better outcomes for everyone involved.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
